Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Current Opinion in Virology|April 23, 2015
Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeuticCaroline J Breitbach, Kelley Parato, James Burke, et al.
Frontiers in Oncology|May 14, 2014
Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1Markus Moehler, Katrin Goepfert, Bernd Heinrich, et al.
Cancer Research Communications|November 12, 2024
Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple MyelomaTodd Shearer, Melissa Comstock, Rex L Williams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2016
Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid CancersStephanie Downs-Canner, Zong Sheng Guo, Roshni Ravindranathan, et al.
Nature|February 15, 2008
Translational control of the innate immune response through IRF-7Rodney Colina, Mauro Costa-Mattioli, Ryan J O Dowling, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2007
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flowCaroline J Breitbach, Jennifer M Paterson, Chantal G Lemay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2011
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanomaTae-Ho Hwang, Anne Moon, James Burke, et al.
Science Translational Medicine|May 17, 2013
Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humansMi Kyung Kim, Caroline J Breitbach, Anne Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinomaNehad M Alajez, Joseph D Mocanu, Wei Shi, et al.
Oncolytic Virotherapy|December 13, 2018
Development and applications of oncolytic Maraba virus vaccinesJonathan G Pol, Matthew J Atherton, Byram W Bridle, et al.
Pageof 4